tiprankstipranks
Trending News
More News >

Beximco Pharma Clarifies Media Accusations

Beximco Pharma Clarifies Media Accusations

Beximco Pharmaceuticals Limited Sponsored GDR RegS (GB:BXP) has released an update.

Confident Investing Starts Here:

Beximco Pharmaceuticals Ltd has issued a statement to correct recent media reports in Bangladesh accusing the company of money laundering and involvement in fraudulent loans. The company clarified that it holds a minor stake in Jubail Pharma, received through a technology transfer agreement and approved by the Bangladesh Central Bank, but has no operational involvement with Jubail Pharma. Furthermore, Beximco Pharma is not implicated in the loan-related allegations against the Beximco Group and its Non-Executive Vice-Chairman’s legal issues do not affect the company’s daily operations.

For further insights into GB:BXP stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App